REGENXBIO FY2025 EPS Forecast Reduced by Chardan Capital
REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Chardan Capital dropped their FY2025 earnings per share estimates for REGENXBIO in a research report issued to clients and investors on Wednesday, May 14th. Chardan Capital analyst D. Gataulin now anticipates that the biotechnology company will post earnings of ($3.25) per share for the year, down from their […]
REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Chardan Capital dropped their FY2025 earnings per share estimates for REGENXBIO in a research report issued to clients and investors on Wednesday, May 14th. Chardan Capital analyst D. Gataulin now anticipates that the biotechnology company will post earnings of ($3.25) per share for the year, down from their […]
